The 3 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 4.00 and a low estimate of 1.50. The median estimate represents a +454.63% increase from the last price of 0.54.
The current consensus among 4 polled investment analysts is to Buy stock in Infinity Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.06
Reporting Date Mar 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.